‪Douglas Lorne Arnold, MD, FRCP(C)‬

Citirano

	Sve	Od 2020.
Citati	61129	21382
H-indeks	127	66
i10-indeks	415	279

4400

2200

1100

3300

19911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025163 145 178 225 306 291 450 521 713 812 1076 1134 1076 1173 1356 1234 1278 1342 1330 1404 1365 1705 1983 2206 2376 2686 3095 3162 3446 3671 4320 4304 4184 4222 623

Javni pristup

Prikaži sve

97 članaka

29 članaka

dostupno

nije dostupno

Na temelju uvjeta financiranja

Suautori

Amit Bar-OrProfessor, University of PennsylvaniaPotvrđena adresa e-pošte na pennmedicine.upenn.edu
Sridar Narayanan, PhDAssistant Professor: Department of Neurology and Neurosurgery, McGill UniversityPotvrđena adresa e-pošte na mcgill.ca
Paul M. MatthewsEdmond and Lily Safra Chair, Professor of Clinical Neurosciences, Imperial College LondonPotvrđena adresa e-pošte na imperial.ac.uk
D. Louis CollinsProfessor of Biomedical Engineering and Neurology & Neurosurgery, McGill UniversityPotvrđena adresa e-pošte na mcgill.ca
Nicola De StefanoProfessor of Neurology, Universtiy of Siena,Potvrđena adresa e-pošte na unisi.it
Gavin GiovannoniQueen Mary University of LondonPotvrđena adresa e-pošte na giovannoni.net
Jerry S Wolinsky, MDEmeritus Professor in Neurology, McGovern Medical School, UTHealth, The University of Texas HealthPotvrđena adresa e-pošte na uth.tmc.edu
Zografos CaramanosMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill UniversityPotvrđena adresa e-pošte na mcgill.ca
Fernando CendesFull Professor, Department of Neurology, FCM, University of Campinas - UNICAMP, BrazilPotvrđena adresa e-pošte na unicamp.br
Jeffrey A CohenCleveland ClinicPotvrđena adresa e-pošte na ccf.org
Robert J FoxMellen Center for Multiple Sclerosis, Cleveland ClinicPotvrđena adresa e-pošte na ccf.org
eric shoubridgeProfessor, Human Genetics, McGill UniversityPotvrđena adresa e-pošte na ericpc.mni.mcgill.ca
Li Min LiProfessor of Neurology, Faculty of Medical Sciences at University of CampinasPotvrđena adresa e-pošte na fcm.unicamp.br
Robert A BrownUniversity of Calgary; Montreal Neurological Institute; ShadowLab Research Inc.Potvrđena adresa e-pošte na shadowlabresearch.com
Bruce PikeCAIP Chair in Healthy Brain Aging, Head of Image Science, Professor - U of CalgaryPotvrđena adresa e-pošte na ucalgary.ca
John G. SledSenior Scientist, Hospital for Sick Children / Professor, University of TorontoPotvrđena adresa e-pošte na utoronto.ca
Emmanuelle WaubantProfessor of Neurology and PediatricsPotvrđena adresa e-pošte na ucsf.edu
Colm ElliottNeuroRx ResearchPotvrđena adresa e-pošte na neurorx.com
Alasdair ColesUniversity of CambridgePotvrđena adresa e-pošte na medschl.cam.ac.uk
Tal ArbelProfessor of Electrical & Computer Engineering, McGill UniversityPotvrđena adresa e-pošte na cim.mcgill.ca

Prati

Douglas Lorne Arnold, MD, FRCP(C)

James McGill Professor: Department of Neurology and Neurosurgery, Faculty of Medicine, McGill

Potvrđena adresa e-pošte na mcgill.ca - Početna stranica

Magnetic Resonance Imaging Neurological Disorders Multiple Sclerosis Alzheimer's Disease


Naslov Poredaj po navodima Poredaj po godini Poredaj po naslovu	Citirano Citirano	Godina
B-cell depletion with rituximab in relapsing–remitting multiple sclerosis SL Hauser, E Waubant, DL Arnold, T Vollmer, J Antel, RJ Fox, A Bar-Or, ... New England Journal of Medicine 358 (7), 676-688, 2008	2858	2008
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis X Montalban, SL Hauser, L Kappos, DL Arnold, A Bar-Or, G Comi, ... N Engl J Med 376 (3), 209-220, 2017	2126	2017
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis R Gold, L Kappos, DL Arnold, A Bar-Or, G Giovannoni, K Selmaj, ... New England Journal of Medicine 367 (12), 1098-1107, 2012	2123	2012
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis SL Hauser, A Bar-Or, G Comi, G Giovannoni, HP Hartung, B Hemmer, ... N Engl J Med 376 (3), 221-234, 2017	2042	2017
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial JA Cohen, AJ Coles, DL Arnold, C Confavreux, EJ Fox, HP Hartung, ... The Lancet 380 (9856), 1819-1828, 2012	1325	2012
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial AJ Coles, CL Twyman, DL Arnold, JA Cohen, C Confavreux, EJ Fox, ... The lancet 380 (9856), 1829-1839, 2012	1306	2012
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P ... Lancet 391 (10127), 1263-1273, 2018	1075	2018
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability N De Stefano, S Narayanan, GS Francis, R Arnaoutelis, MC Tartaglia, ... Archives of neurology 58 (1), 65-70, 2001	685	2001
Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy MC Preul, Z Caramanos, DL Collins, JG Villemure, R Leblanc, A Olivier, ... Nature medicine 2 (3), 1996	682	1996
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: Results of a longitudinal magnetic resonance spectroscopy study N De Stefano, PM Matthews, L Fu, S Narayanan, J Stanley, GS Francis, ... Brain 121 (Pt 8), 1469-1477, 1998	629	1998
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial A Bar‐Or, PAJ Calabresi, D Arnold, C Markowitz, S Shafer, LH Kasper, ... Annals of neurology 63 (3), 395-400, 2008	614	2008
Imaging axonal damage of normal-appearing white matter in multiple sclerosis L Fu, PM Matthews, N De Stefano, KJ Worsley, S Narayanan, GS Francis, ... Brain 121 (1), 103-113, 1998	608	1998
Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region N Bernasconi, A Bernasconi, Z Caramanos, SB Antel, F Andermann, ... Brain 126 (2), 462-469, 2003	591	2003
Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR DL Arnold, PM Matthews, GK Radda Magnetic resonance in medicine 1 (3), 307-315, 1984	580	1984
Reversible decreases in N‐acetylaspartate after acute brain injury ND Stefano, PM Matthews, DL Arnold Magnetic Resonance in Medicine 34 (5), 721-727, 1995	538	1995
Exploring uncertainty measures in deep networks for Multiple sclerosis lesion detection and segmentation AT Nair T, Precup D, Arnold DL Med Image Anal 59, 101557, 2020	521	2020
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study PA Calabresi, BC Kieseier, DL Arnold, LJ Balcer, A Boyko, J Pelletier, ... The Lancet Neurology 13 (7), 657-665, 2014	477	2014
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled … Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model ... JAMA Neurol [PMID: 32511687; Epub: 2020/06/09] 77 (9), 1132-1140, 2020	473*	2020
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging D Garcia-Lorenzo, S Francis, S Narayanan, DL Arnold, DL Collins Medical image analysis 17 (1), 1-18, 2013	464	2013
Incidence of acquired demyelination of the CNS in Canadian children B Banwell, J Kennedy, D Sadovnick, DL Arnold, S Magalhaes, ... Neurology 72 (3), 232-239, 2009	422	2009

Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.

Članci 1–20

Godišnji broj citata

Dvostruki navodi

Spojeni navodi

Dodavanje suautoraSuautori

Prati

Citirano

Suautori